Virtu Financial’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-31,852
| Closed | -$19K | – | 2503 |
|
|
2022
Q2 | $19K | Buy |
31,852
+547
| +2% | +$326 | ﹤0.01% | 1349 |
|
|
2022
Q1 | $41K | Buy |
+31,305
| New | +$41K | ﹤0.01% | 1181 |
|
|
2021
Q1 | – | Sell |
-28,821
| Closed | -$97K | – | 2239 |
|
|
2020
Q4 | $97K | Buy |
+28,821
| New | +$97K | 0.01% | 1065 |
|
|
2019
Q4 | $82K | Buy |
+13,422
| New | +$82K | 0.01% | 1121 |
|